2019 Platinum, Gold and Silver Sponsors

Acelity

Acelity is a global wound care company created by leveraging the strengths of Kinetic Concepts, Inc. (KCI) and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Nearly 5,000 employees worldwide support Acelity’s mission to change the practice of medicine with solutions that speed healing, reduce complications, create economic value and improve patient’s lives in over 80 countries.

Through an innovative and comprehensive product portfolio combined with specialized knowledge that leads the industry in quality, safety and customer experience, we are committed to providing safe and effective medical products with integrity and compliance.

Our vision to restore people’s lives also extends to the communities we serve. Each year, we donate millions of dollars and products to help people impacted by global tragic disasters. Our most recent product donations supported global relief efforts in Brussels, Paris, Orlando and Ecuador. Additionally, our Acelity CHARITY CARE LOANER ™ program allows nearly 8,000 uninsured, low income patients each year to receive V.A.C.®  Therapy for free.

We will continue to act in a manner that minimizes the environmental impact of our business operations, actively encourages support of charitable and educational activities in the community, and maintains the highest standards of integrity, leadership and behavior in all that we do. That’s the Certainty of Acelity.

Mölnlycke

Mölnlycke is a world-leading medical solutions company. We’re here to advance performance in healthcare across the world, and we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. We collaborate with customers to understand their needs. We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home.

  1. Wound management

We advance wound healing with wound care solutions that are backed by clinical evidence, including dressings with Safetac® and negative pressure wound therapy systems. We also provide education and expert support.

  1. Preventing pressure ulcers

 We reduce the risk of pressure ulcers, with prevention solutions such as prophylactic dressings, devices that help healthcare professionals turn and re-position patients and supporting educational and consultancy services.

  1. Surgical solutions

 We improve safety and efficiency in and around the operating room with customized trays including surgical instruments. We also protect staff and patients from infection with surgical drapes, staff clothing, antiseptics and surgical gloves and provide education and expert support.

A pioneering history

Mölnlycke was founded in 1849 in Sweden as a textile manufacturer and has a long history of being at the forefront of healthcare. We pioneered the industrial manufacture of wound dressings, and were the first to offer single-use drapes, tubular bandages and polymer-coated powder-free surgical gloves. We’re also the company behind Safetac® – the revolutionary soft silicone-based technology used in many of our wound care dressings – that results in less pain for patients. Now we’re leading the way in preventing pressure ulcers, with prophylactic dressings and devices for turning and re-positioning patients. Throughout our history, we’ve retained the name Mölnlycke (pronounced ‘Mon-licka’), reflecting the town of Mölnlycke, which grew up around the company. Our headquarters are now in the city of Gothenburg, only a short distance from our birthplace.

Innovating into the future

Driven by our relentless focus on finding solutions for unmet needs in healthcare, we’ll continue to innovate and develop high-quality, cost-effective solutions that set new standards. We’ll work closely with industry bodies, healthcare organizations and governments around the world to shape healthcare policy, inform protocols, and raise standards of care. From nurses and doctors through to hospital managers, homecare providers and procurement professionals, we’ll equip everybody in healthcare to achieve the best outcomes.

Smith & Nephew

Smith & Nephew, a global medical technology business, supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.

We do this by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems.

We have leadership positions in:

  • Orthopedics Reconstruction – joint replacement systems for knees, hips and shoulders
  • Advanced Wound Management – wound care treatment and prevention products used to treat hard-to-heal wounds
  • Sports Medicine – minimally invasive surgery of the joint
  • Trauma and Extremities – products that help repair broken bones

Our values shape everything that we do as a business and form the basis of our relationships with all our stakeholders. Our values also underpin our approach to sustainable development where we continue to set challenging performance targets, particularly with regard to managing our environmental impact and increasingly in the area of social responsibility.

Our values are articulated under the headings of Performance, Innovation and Trust.

PERFORMANCE means being responsive to the needs of our customers, setting ourselves clear goals and standards and achieving them. We deliver quality and value in our products and services that provide quantifiable social and economic benefits. Our product, technique and service developments reduce pain, speed recovery. For example, by getting patients back on their feet more quickly following surgery, or by reducing the time it takes to perform procedures, like a hip replacement, more operations can be performed more cost effectively.

INNOVATION means taking a pioneering approach to the design of our products and services, being energetic, creative and passionate about everything we do. We are forward looking; anticipating customers' needs, overcoming barriers and developing opportunities. We encourage and support new ideas, and are always seeking to improve the lives of healthcare professionals and the patients they treat with effective and safe product and service innovations.

TRUST is something we understand that we have to earn. We earn it by being friendly, approachable and listening to others. We work hard to build lasting and close relationships with our customers, colleagues and the communities in which we operate. We are honest and straightforward and do what we say. We have integrity and an ethical approach to business. Our Code of Business Principles defines our relationships with all of our stakeholders, and the behaviors and conduct they should expect from us in our dealings with them.

Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc., based in Columbia, Maryland, researches, develops, manufactures, and commercializes regenerative medicine products intended to improve the health and lives of patients and lower overall healthcare costs. We have achieved commercial success with products in orthopedics, sports medicine and wound care, including the Grafix product line, Stravix®, BIO, and Cartiform®. We continue to advance our research and development by focusing on innovation in regenerative medicine, including the development of bioengineered stem cell and tissue‑based products.

Grafix, GrafixPL and Stravix are human placental allografts used as an adjunct to good wound care in the treatment of chronic wounds, including but not limited to diabetic ulcers, venous stasis ulcers, pressure ulcers, arterial ulcers, burns, and non-healing surgical and trauma wounds.